Table 1: Characteristics of study group before therapy in a univariate comparison.
Variable |
Mean (SD) or percent RPE |
Mean (SD) or percent ERBT |
p value |
Age |
66.6 (6.52) |
72.55 (6.56) |
< 0.0001 |
Proportion pos. probes |
0.40 (0.27) |
0.36 (0.14) |
0.4612 |
Charlson comorbidity index |
0.68 (0.90) |
1.14 (1.09) |
< 0.0001 |
D’Amico score |
2.88 (1.44) |
2.52 (1.34) |
0.0004 |
Gleason score |
5.79 (1.61) |
6.68 (1.14) |
< 0.0001 |
PSA |
11.14 (12.64) |
12.62 (15.20) |
0.4339 |
Prostate volume |
42.95 (20.22) |
30.01 (17.57) |
< 0.0001 |
Stage cT1a-cT1c - variable 1 cT2a-cT2b - variable 2 cT2c - variable 3 cT3a-cT3b - variable 4 |
60.8% 67.7% 78.1% 35.7% |
39.2% 32.3% 21.9% 64.3%
|
< 0.0001 |